PRF1 and COVID-19: Validation to these findings was observed during the recent COVID-19 pandemic, in which NK cells derived from severe COVID-19 patients, compared to healthy patients showed reduced expression of granzyme A that was associated with IL-6 serum levels, in addition to reduced perforin expression (105).